Wellington Management Group LLP Increases Position in Brookdale Senior Living Inc. (BKD)
- Author: Zachary Reyes Jun 15, 2017,
Jun 15, 2017, 22:28
The hedge fund run by Michael Blitzer held 5.50 million shares of the hospital and nursing management company at the end of 2016Q4, valued at $68.31 million, up from 3.33 million at the end of the previous reported quarter. Bnp Paribas Arbitrage has 0.08% invested in Brookdale Senior Living, Inc. Perhaps, that suggests something about why 75.75% of the outstanding share supply is held by institutional investors. The company's stock has a normal trading capacity of 2.91M shares while the relative volume is 4.76. Wells Fargo raised its rating on Brookdale Senior Living Inc.to Outperform on 12/01/2017 in a reversal from its prior Market Perform rating. (NYSE:BKD) has declined 20.75% since June 13, 2016 and is downtrending. It has underperformed by 37.45% the S&P500.
Vanguard Group Inc increased its stake in Middleby Corp (MIDD) by 4.55% based on its latest 2016Q4 regulatory filing with the SEC. Bce Inc now has $39.98B valuation. About 4,250 shares traded. It has underperformed by 25.78% the S&P500. Guggenheim Capital LLC now owns 14,274 shares of the company's stock worth $177,000 after buying an additional 530 shares during the last quarter. Therefore 55% are positive. Middleby had 7 analyst reports since November 12, 2015 according to SRatingsIntel. Traditionally the RSI is considered overbought when above 70 and oversold when below 30. (NYSE:BKD) earned "Top Pick" rating by RBC Capital Markets on Friday, November 6. The company was maintained on Wednesday, August 5 by Barclays Capital. The firm has "Equal-Weight" rating by Barclays Capital given on Wednesday, January 6. ValuEngine downgraded Brookdale Senior Living from a "buy" rating to a "hold" rating in a research note on Friday, June 2nd. Brookdale Senior Living, Inc. Jefferies upgraded it to "Buy" rating and $16.50 target in Monday, March 27 report.
BioCryst Pharmaceuticals, Inc. (BCRX) announced that executives from the Company are scheduled to provide a corporate summary and update regarding the Company's clinical programs at the JMP Securities 2017 Life Sciences Conference in NY on Wednesday, June 21, 2017 at 9:30 a.m. The firm earned "Outperform" rating on Wednesday, January 13 by Macquarie Research.
The return on invested capital at -0.6%, which is good, compared to its peers. Its up 0.27, from 1.01 in 2016Q3.
Brookdale Senior Living Inc. has a consensus outperform rating from 8 Wall Street analysts, and the number of shares now sold short amount to at least 7.01% of shares outstanding. Brookfield Asset Management Inc. raised its position in Brookdale Senior Living by 34.5% in the fourth quarter. 194.95 million shares or 1.86% more from 191.40 million shares in 2016Q3 were reported. Analysts are forecasting earnings of $0.5 on a per share basis this quarter. Creative Planning holds 0% or 547 shares in its portfolio. Princeton Port Strategies Grp Inc Limited Liability holds 0.23% or 58,706 shares in its portfolio.
Bnp Paribas Arbitrage owns 1.30 million shares for 0.08% of their portfolio. Eaton Vance Mngmt, Massachusetts-based fund reported 17,367 shares.
Brookdale Senior Living Inc. has a 1-year low of $10.65 and a 1-year high of $18.62. (NYSE:BKD) for 959,919 shares. (NYSE:BKD). Stratos Wealth Ltd invested in 11,879 shares or 0.01% of the stock. Ubs Asset Management Americas invested 0% of its portfolio in Brookdale Senior Living, Inc. (NYSE:BKD). 44,445 were accumulated by Employees Retirement Association Of Colorado. Allen Holding owns 3.41% invested in Expedia Inc (NASDAQ:EXPE) for 137,423 shares. (NYSE:BKD) news were published by: Reuters.com which released: "Exclusive: SeaWorld's Chinese investor in talks to buy Brookdale Senior Living ..." on June 13, 2017, also Nasdaq.com with their article: "BUZZ-US STOCKS ON THE MOVE-H&R Block, Brookdale Senior Living, Alexion" published on June 14, 2017, Prnewswire.com published: "Healthcare Stock Performance Review - Brookdale Senior Living, BioScrip ..." on June 14, 2017. The 52-week range of the share price is from $57.89 - $72.72, while its earnings per share (EPS) stand at $1.43. Jennison Assocs Limited Liability Company reported 826,420 shares stake.